Leerink Partners is a leading investment bank providing a complete suite of financial solutions comprising M&A advisory, equity, debt, and derivative capital markets, equity research, and sales and trading capabilities. The firm’s strategic focus on the healthcare industry empowers it to provide unique advice and insights to its clients. The firm is a broker-dealer registered with the United States Securities and Exchange Commission and a member of the Financial Industry Regulatory Authority. SVB Securities LLC is doing business as Leerink Partners.
External link for Leerink Partners
One Federal Street
37th Floor
Boston, MA 02110, US
1301 Avenue of the Americas
12th Floor
New York, NC 10019, US
255 California Street
12th Floor
San Francisco, California 94111, US
227 W Trade Street
Charlotte, North Carolina 28202, US
Leerink Partners reposted this
Check your inboxes for our next newsletter! It summarizes the CPE Exclusive we released last week following the approval of Attruby™ for ATTR cardiomyopathy. If you didn’t receive it, visit https://lnkd.in/gpVjMp5n The Leerink Center for Pharmacoeconomics is a division of MEDACorp which is an affiliate of Leerink Partners.
We are pleased to serve as sole placement agent for Senti Biosciences’ $38 Million Private Placement. Learn more about us and see all of our transactions online at https://lnkd.in/eGZsdSw
Leerink Center for Pharmacoeconomics (CPE) released their next CPE Exclusive, focused on Attruby for Transthyretin Amyloid Cardiomyopathy. Read the full report at: https://lnkd.in/eWE98CnV The Leerink Center for Pharmacoeconomics is a division of MEDACorp which is an affiliate of Leerink Partners.
We are pleased to serve as sole bookrunner for Replimune’s Upsized $140 Million Follow-On Offering. Learn more about us and see all of our transactions online at https://lnkd.in/eGZsdSw
We are excited to share the next episode of Perspectives by Leerink Partners. Diane Vieira, Managing Director of Marketing & Communications at Leerink Partners, interviews Melanie Whittington, PhD, Head of the Leerink Center for Pharmacoeconomics. In this episode they discuss the origin of pharmacoeconomics, its societal importance, and staying true to your authentic self. Listen to the full episode now: Apple Podcasts: https://lnkd.in/g6tn3TXa Spotify: https://lnkd.in/g_-tN88Q The Leerink Center for Pharmacoeconomics is a division of MEDACorp which is an affiliate of Leerink Partners.
We are excited to announce that Holden Hodgson has joined our Derivatives team. Click here to view the full press release: https://lnkd.in/eAmEVa_6
We are pleased to serve as financial advisor and placement agent to Aclaris Therapeutics on its Global License Agreement with Biosion and $80 Million Private Placement. Learn more about us and see all of our transactions online at https://lnkd.in/eGZsdSw
We are pleased to serve as joint bookrunner for Zai Lab’s $200 Million Follow-On Offering. Learn more about us and see all of our transactions online at https://lnkd.in/eGZsdSw
We are excited to welcome Grant Curry and Jason Truman to our Mergers & Acquisitions team. Click here to view the full press release: https://lnkd.in/exEi6gXm
We are pleased to serve as joint bookrunner for 89bio’s Upsized $125 Million Follow-On Offering. Learn more about us and see all of our transactions online at https://lnkd.in/eGZsdSw